DK0456720T3 - Granuleringer med højt ibuprofenindhold - Google Patents
Granuleringer med højt ibuprofenindholdInfo
- Publication number
- DK0456720T3 DK0456720T3 DK90902888.8T DK90902888T DK0456720T3 DK 0456720 T3 DK0456720 T3 DK 0456720T3 DK 90902888 T DK90902888 T DK 90902888T DK 0456720 T3 DK0456720 T3 DK 0456720T3
- Authority
- DK
- Denmark
- Prior art keywords
- binder
- percent
- polyvinylpyrrolidone
- granules
- ibuprofen
- Prior art date
Links
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 title abstract 3
- 229960001680 ibuprofen Drugs 0.000 title abstract 3
- 239000008187 granular material Substances 0.000 title 1
- 239000011230 binding agent Substances 0.000 abstract 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 3
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 238000007907 direct compression Methods 0.000 abstract 1
- 239000006185 dispersion Substances 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 238000005469 granulation Methods 0.000 abstract 1
- 230000003179 granulation Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/306,014 US4911921A (en) | 1989-02-02 | 1989-02-02 | High ibuprofen content granulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0456720T3 true DK0456720T3 (da) | 1995-08-14 |
Family
ID=23183358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK90902888.8T DK0456720T3 (da) | 1989-02-02 | 1990-01-31 | Granuleringer med højt ibuprofenindhold |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4911921A (da) |
| EP (1) | EP0456720B1 (da) |
| JP (1) | JP2556623B2 (da) |
| AT (1) | ATE124257T1 (da) |
| AU (1) | AU629913B2 (da) |
| CA (1) | CA2045680C (da) |
| DE (1) | DE69020541T2 (da) |
| DK (1) | DK0456720T3 (da) |
| ES (1) | ES2076358T3 (da) |
| WO (1) | WO1990008542A1 (da) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5104648A (en) * | 1989-02-02 | 1992-04-14 | Mallinckrodt Specialty Chemicals Company | High ibuprofen content granulations |
| US5087454A (en) * | 1990-07-30 | 1992-02-11 | American Home Products Corporation | Ibuprofen tablet |
| GB9119052D0 (en) * | 1991-09-06 | 1991-10-23 | Boots Co Plc | Pharmaceutical compositions |
| US5191114A (en) * | 1991-10-09 | 1993-03-02 | Sage Pharmaceuticals, Inc. | Process for enhancing the flow characteristics of ibuprofen |
| US5310961A (en) * | 1993-07-02 | 1994-05-10 | Affinity Biotech, Inc. | Neomorphic ibuprofen |
| US6348216B1 (en) * | 1996-06-10 | 2002-02-19 | Knoll Pharmaceutical Company | Ibuprofen and narcotic analgesic compositions |
| US6361794B1 (en) | 1996-06-12 | 2002-03-26 | Basf Corporation | Method of making ibuprofen and narcotic analgesic composition |
| US5837292A (en) * | 1996-07-03 | 1998-11-17 | Yamanouchi Europe B.V. | Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug |
| FR2772617B1 (fr) * | 1997-12-19 | 2001-03-09 | Besins Iscovesco Lab | Comprime de progesterone et son procede de preparation |
| IT1301966B1 (it) | 1998-07-30 | 2000-07-20 | Zambon Spa | Composizioni farmaceutiche ad attivita' analgesica |
| HUP0104606A3 (en) * | 1998-12-18 | 2003-01-28 | Basf Ag | A pharmaceutical mixture comprising a profen |
| US6251945B1 (en) | 1999-01-14 | 2001-06-26 | Knoll Aktiengesellschaft | Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| DE10003757A1 (de) * | 2000-01-28 | 2001-08-02 | Knoll Ag | Ibuprofen-Wirkstoffzubereitung |
| GB0209265D0 (en) | 2002-04-23 | 2002-06-05 | Novartis Ag | Organic compounds |
| CZ296100B6 (cs) † | 2002-04-29 | 2006-01-11 | EGIS Gyógyszergyár Rt. | Zpusob prípravy tablet z farmaceuticky aktivních látek majících nevýhodné tabletacní vlastnosti s granulacní kapalinou obsahující mikrokrystalickou celulózu |
| CH693586A8 (de) * | 2002-10-14 | 2003-12-15 | Roche Consumer Health Ag | Darreichungsform von Ibuprofen-Natrium. |
| US20040253308A1 (en) * | 2003-04-29 | 2004-12-16 | Barr Laboratories, Inc. | Surface-treated modafinil particles |
| EP1765296A2 (en) * | 2004-06-30 | 2007-03-28 | Albemarle Corporation | High ibuprofen content granules and their preparation and use |
| HRP20080297T3 (en) | 2004-07-30 | 2008-07-31 | Torrent Pharmaceuticals Ltd | Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol |
| DK1884242T3 (da) | 2005-05-26 | 2013-05-06 | Dainippon Sumitomo Pharma Co | Farmaceutisk sammensætning omfattende lurasidon |
| CA2577760A1 (en) * | 2006-02-27 | 2007-08-27 | Tyco Healthcare Group Lp | Pressurized dip coating system |
| US20080069889A1 (en) * | 2006-03-07 | 2008-03-20 | Cherukuri S R | Compressible resilient granules and formulations prepared therefrom |
| US20070212417A1 (en) * | 2006-03-07 | 2007-09-13 | Cherukuri S R | Compressible resilient granules and formulations prepared therefrom |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3108046A (en) * | 1960-11-25 | 1963-10-22 | Smith Kline French Lab | Method of preparing high dosage sustained release tablet and product of this method |
| US4209513A (en) * | 1974-02-14 | 1980-06-24 | Burroughs Wellcome Co. | Tablet formulation |
| US4661521A (en) * | 1984-04-30 | 1987-04-28 | Mallinckrodt, Inc. | Direct tableting acetaminophen compositions |
| US4609675A (en) * | 1984-08-17 | 1986-09-02 | The Upjohn Company | Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing |
| US4753801A (en) * | 1985-10-25 | 1988-06-28 | Eli Lilly And Company | Sustained release tablets |
| US4757090A (en) * | 1986-07-14 | 1988-07-12 | Mallinckrodt, Inc. | Direct tableting acetaminophen compositions |
| US4806359A (en) * | 1987-04-22 | 1989-02-21 | Mcneilab, Inc. | Iburprofen sustained release matrix and process |
| US4837031A (en) * | 1987-09-17 | 1989-06-06 | Mallinckrodt, Inc. | Compositions containing ibuprofen |
-
1989
- 1989-02-02 US US07/306,014 patent/US4911921A/en not_active Expired - Lifetime
-
1990
- 1990-01-31 DK DK90902888.8T patent/DK0456720T3/da active
- 1990-01-31 AU AU50369/90A patent/AU629913B2/en not_active Expired
- 1990-01-31 ES ES90902888T patent/ES2076358T3/es not_active Expired - Lifetime
- 1990-01-31 AT AT90902888T patent/ATE124257T1/de not_active IP Right Cessation
- 1990-01-31 CA CA002045680A patent/CA2045680C/en not_active Expired - Lifetime
- 1990-01-31 EP EP90902888A patent/EP0456720B1/en not_active Expired - Lifetime
- 1990-01-31 WO PCT/US1990/000564 patent/WO1990008542A1/en not_active Ceased
- 1990-01-31 DE DE69020541T patent/DE69020541T2/de not_active Expired - Lifetime
- 1990-01-31 JP JP2503127A patent/JP2556623B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2076358T3 (es) | 1995-11-01 |
| DE69020541D1 (de) | 1995-08-03 |
| CA2045680A1 (en) | 1990-08-03 |
| AU5036990A (en) | 1990-08-24 |
| EP0456720A1 (en) | 1991-11-21 |
| ATE124257T1 (de) | 1995-07-15 |
| WO1990008542A1 (en) | 1990-08-09 |
| US4911921A (en) | 1990-03-27 |
| DE69020541T2 (de) | 1995-11-02 |
| CA2045680C (en) | 1997-01-14 |
| JP2556623B2 (ja) | 1996-11-20 |
| AU629913B2 (en) | 1992-10-15 |
| JPH04503069A (ja) | 1992-06-04 |
| EP0456720B1 (en) | 1995-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE124257T1 (de) | Granulate mit hohem ibuprofengehalt. | |
| ATE125155T1 (de) | Niedrigdosierte getrocknete pharmazeutische präparate. | |
| ATE84705T1 (de) | Ein freifliessendes granulat, enthaltend ibuprofen und ein herstellunsgverfahren. | |
| ATE160696T1 (de) | Tabletten, granulate und pellets mit hohem gehalt an wirkstoffen für hochkonzentrierte, feste darreichungsformen | |
| DK0698389T3 (da) | Matrix med reguleret frigivelse til farmaceutiske præparater | |
| ATE86479T1 (de) | Pharmazeutische matrix mit verzoegerter freisetzung und verfahren. | |
| DE69001488D1 (de) | Mittel auf gemfibrozilbasis mit modifizierter freigabe. | |
| NZ228970A (en) | Chewable tablet comprising granules and an extragranular hygroscopic excipient | |
| DE69031950D1 (de) | Kleine partikeln enthaltende arzneistoffzusammensetzung | |
| IT1235053B (it) | Metodi per la preparazione di composizioni farmaceutiche a base di bromocriptina dotate di elevata stabilita' e prodotti derivanti. | |
| ATE239456T1 (de) | Pharmazeutische formulierung in form eines trockenen pulvers | |
| JPH0813736B2 (ja) | 単斜結晶構造を有する熱―、光―、及び湿気―感受性活性成分を含む錠剤又は糖剤組成物の調製方法 | |
| ATE97572T1 (de) | Azelastin enthaltende arzneimittel mit kontrollierter wirkstoffabgabe. | |
| FR2656772B1 (fr) | Procede d'incorporation dans des pellets de principes actifs proteges contre la degradation dans la panse des ruminants. | |
| IL82065A0 (en) | Pellet-containing delayed release pharmaceutical and veterinary composition and its preparation | |
| JPS5726615A (en) | Improving method for absorbability of slightly soluble drug | |
| JPS5781409A (en) | External plaster | |
| ES2093192T3 (es) | Formulacion farmaceutica con elevado contenido de lisinato de ibuprofeno. | |
| Hontz | Assessment of Selected formulation and processing variables in fluid bed granulation | |
| JPS57112328A (en) | Hypotensor comprising 2,3-dihydroxypropyl ester of n-(7- chloro-4-quinolyl)anthranillic acid | |
| JPS56122316A (en) | Stabilizing method of drug |